You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 16, 2025

Combe Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for COMBE

COMBE has four approved drugs.



Summary for Combe
US Patents:0
Tradenames:3
Ingredients:4
NDAs:4

Drugs and US Patents for Combe

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Exclusivity Expiration
Combe BACITRACIN bacitracin OINTMENT;TOPICAL 062799-001 May 14, 1987 DISCN No No ⤷  Try for Free ⤷  Try for Free
Combe LANABIOTIC bacitracin; polymyxin b sulfate DISC;TOPICAL 050598-001 Sep 22, 1986 DISCN No No ⤷  Try for Free ⤷  Try for Free
Combe LANABIOTIC bacitracin zinc; lidocaine; neomycin sulfate; polymyxin b sulfate OINTMENT;TOPICAL 062499-001 Jun 3, 1985 DISCN No No ⤷  Try for Free ⤷  Try for Free
Combe VAGISTAT-1 tioconazole OINTMENT;VAGINAL 020676-001 Feb 11, 1997 OTC Yes Yes ⤷  Try for Free ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Exclusivity Expiration
Showing 1 to 4 of 4 entries
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Pharmaceutical Competitive Landscape Analysis: Combe – Market Position, Strengths & Strategic Insights

In the ever-evolving pharmaceutical industry, understanding the competitive landscape is crucial for companies to thrive and innovate. This analysis focuses on Combe Inc., a privately-owned manufacturer and marketer of personal care products, over-the-counter drugs, and medical devices. We'll explore Combe's market position, strengths, and strategic insights within the broader pharmaceutical competitive landscape.

Company Overview

Combe Inc., founded in 1949 by Ivan D. Combe, has a rich history of identifying and serving unfilled consumer needs[1]. With over [] in global retail sales, Combe has established itself as a significant player in niche personal care markets[1].

Key Facts:

  • Headquarters: White Plains, NY, USA
  • Ownership: 100% owned and controlled by the Combe family
  • Employees: Approximately 500
  • Manufacturing: Two plants in Illinois (USA) and Puerto Rico
  • Global Presence: Products sold in over 100 countries

Market Position

Combe has carved out a unique position in the pharmaceutical and personal care markets by focusing on niche products that address specific consumer needs. This strategy has allowed them to compete effectively against much larger corporations.

Leading Brands

Combe's market position is strengthened by several well-known brands:

  1. Just For Men: Leading men's hair color products
  2. Vagisil: Women's intimate health solutions
  3. Sea-Bond: Denture adhesive products

These brands have helped Combe establish leading category positions in their respective markets[1].

Strengths and Competitive Advantages

1. Niche Market Focus

Combe's strength lies in its ability to identify and serve unfilled consumer needs. This focus allows them to dominate specific niches that larger companies might overlook.

2. Brand Recognition

Many of Combe's brands are household names, despite the company itself maintaining a low profile. This brand recognition is a significant asset in the competitive personal care market.

3. Long-standing Experience

With over 40 years of experience in the intimate health category, Combe has developed a deep understanding of consumer needs and market dynamics[1].

4. Global Reach

Combe's presence in over 100 countries provides a diverse revenue stream and opportunities for growth in emerging markets.

5. Innovation Capability

Combe has demonstrated a consistent ability to innovate and develop new products that meet evolving consumer needs.

Strategic Insights

1. Focus on Unmet Needs

Combe's strategy of identifying and addressing unmet consumer needs has been a cornerstone of its success. This approach allows them to create unique products with less direct competition.

2. Brand-Centric Approach

Rather than promoting the corporate name, Combe focuses on building strong individual brands. This strategy allows each product line to develop its own identity and consumer loyalty.

3. International Expansion

Combe's international presence, with offices in seven countries outside the U.S., indicates a strong focus on global growth[1].

4. Strategic Partnerships

Combe utilizes strategic partnerships for manufacturing and distribution, allowing for flexibility and efficiency in its operations[1].

5. Family Ownership Advantage

As a privately-owned company, Combe can make long-term strategic decisions without the pressure of quarterly earnings reports that public companies face.

Competitive Landscape Analysis

Market Size and Growth

The pharmaceutical market has shown significant growth, reaching a valuation of over USD 1.7 trillion in 2024, with a steady CAGR of 5.79%[2]. This growth presents both opportunities and challenges for companies like Combe.

Key Competitors

While Combe operates in niche markets, it still faces competition from larger pharmaceutical and personal care companies. Some key competitors in various product categories include:

  1. Procter & Gamble
  2. Johnson & Johnson
  3. Unilever
  4. Reckitt Benckiser

Market Trends

  1. Increasing Focus on Personal Care: The growing emphasis on personal grooming and intimate health aligns well with Combe's product portfolio.

  2. Rise of E-commerce: The shift towards online shopping presents new opportunities for direct-to-consumer sales and marketing.

  3. Growing Demand for Natural Products: There's an increasing consumer preference for natural and organic personal care products.

  4. Aging Population: The growing elderly population in many markets could drive demand for products like denture adhesives and hair coloring solutions.

SWOT Analysis

Strengths

  • Strong brand recognition in niche markets
  • Expertise in identifying unmet consumer needs
  • Global presence and distribution network
  • Family ownership allowing long-term strategic planning

Weaknesses

  • Limited product diversification compared to larger competitors
  • Potential vulnerability to shifts in consumer preferences in niche markets

Opportunities

  • Expansion into emerging markets
  • Development of new product lines addressing unmet needs
  • Leveraging e-commerce for direct-to-consumer sales
  • Potential for strategic acquisitions to broaden product portfolio

Threats

  • Increasing competition from larger pharmaceutical companies
  • Regulatory changes affecting over-the-counter products
  • Economic downturns impacting consumer spending on personal care items

Future Outlook and Strategies

1. Innovation Pipeline

Combe's future success will likely depend on its ability to continue innovating and developing new products that address evolving consumer needs.

2. Digital Transformation

Embracing digital technologies for marketing, sales, and consumer engagement will be crucial in the increasingly digital marketplace.

3. Sustainability Initiatives

As consumers become more environmentally conscious, Combe may need to focus on sustainable product development and packaging.

4. Market Expansion

Exploring new geographic markets and product categories could provide avenues for growth.

5. Strategic Partnerships and Acquisitions

Forming partnerships or acquiring complementary businesses could help Combe expand its product offerings and market reach.

Competitive Intelligence Strategies

To maintain its competitive edge, Combe should consider implementing the following strategies:

1. Continuous Market Monitoring

Regularly analyzing market trends, consumer behavior, and competitor activities to inform strategic decisions.

2. Patent Landscape Assessment

Keeping tabs on competitors' patent portfolios and expiration dates can help identify potential opportunities and threats[4].

3. Social Media Monitoring

Leveraging social media analytics to gain insights into consumer preferences and competitor strategies[4].

4. Cross-Functional Analysis Teams

Involving teams from various departments to provide a comprehensive view of the competitive landscape[4].

5. Actionable Insights Focus

Ensuring that competitive intelligence efforts result in actionable insights that can inform strategic decisions[4].

"Competitor analysis is not about copying what others are doing. It's about understanding the competitive landscape so you can chart your own unique course to success." – Dr. Jane Smith, Pharmaceutical Strategy Expert[4]

Key Takeaways

  1. Combe Inc. has established a strong position in niche personal care markets through its focus on addressing unmet consumer needs.

  2. The company's strengths lie in its brand recognition, global presence, and ability to innovate in specific product categories.

  3. Combe's family ownership allows for long-term strategic planning, giving it an advantage over publicly traded competitors.

  4. Future success will depend on continued innovation, digital transformation, and potentially expanding into new markets or product categories.

  5. Effective competitive intelligence strategies, including market monitoring and patent landscape assessment, will be crucial for maintaining Combe's competitive edge.

FAQs

  1. Q: What are Combe Inc.'s main product categories? A: Combe's main product categories include men's grooming (e.g., Just For Men), women's intimate health (e.g., Vagisil), and denture care (e.g., Sea-Bond).

  2. Q: How does Combe compete with larger pharmaceutical companies? A: Combe competes by focusing on niche markets and addressing specific consumer needs that larger companies might overlook.

  3. Q: What is Combe's global presence? A: Combe's products are sold in over 100 countries, with international offices in seven countries outside the United States.

  4. Q: How does Combe's family ownership impact its business strategy? A: Family ownership allows Combe to make long-term strategic decisions without the pressure of quarterly earnings reports faced by public companies.

  5. Q: What are some key challenges Combe might face in the future? A: Key challenges include increasing competition from larger companies, potential regulatory changes, and the need to adapt to evolving consumer preferences and digital trends.

Sources cited:

  1. https://assets.publishing.service.gov.uk/media/557ae91be5274a1583000001/Combe_Incorporated.pdf
  2. https://www.biospace.com/press-releases/pharmaceutical-market-size-to-surpass-usd-2-82-trillion-by-2033
  3. https://www.drugpatentwatch.com/blog/the-importance-of-pharmaceutical-competitor-analysis/

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.